Prosecution Insights
Prosecution Insights
18 pending office actions • 12 clients • 17 examiners • 15 art units • 0 of 18 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 18 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 18 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 13 (72%) |
| §102 only | 1 (6%) |
| §112 only | 1 (6%) |
| No statute on record | 3 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAMANA, ANURADHA | 2 | 82.7% | +22.5% |
| YU, HONG | 1 | 31.2% | +5.7% |
| TCHERKASSKAYA, OLGA V | 1 | 55.4% | +46.6% |
| BARSKY, JARED | 1 | 50.2% | +23.0% |
| SCHUBERG, LAURA J | 1 | 23.7% | +36.7% |
| GONZALES, JOSEPHINE MARIA | 1 | 29.8% | +42.1% |
| HILL, KEVIN KAI | 1 | 36.2% | +33.4% |
| BURKHART, MICHAEL D | 1 | 62.4% | +10.9% |
| WANG, RUIXUE | 1 | 57.6% | +23.2% |
| GILL, RACHEL B | 1 | 65.6% | +27.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18099486 | MAGNETIC INTERVERTEBRAL DISC REPLACEMENT DEVICES AND METHODS THEREOF | RAMANA, ANURADHA | 29d |
| 18099505 | MAGNETIC INTERVERTEBRAL DISC REPLACEMENT DEVICES AND METHODS THEREOF | RAMANA, ANURADHA | 30d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18003124 | ENDOTHELIAL CELLS FOR MITIGATION OF CHEMOTHERAPY-INDUCED TOXICITY | SCHUBERG, LAURA J | 25d overdue |
| 18066567 | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF ADENO-ASSOCIATED VIRUS | GONZALES, JOSEPHINE MARIA | 69d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18138058 | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION | BARSKY, JARED | 89d overdue |
| 18009320 | CHIMERIC ANTIGEN RECEPTOR CELL | HILL, KEVIN KAI | 86d overdue |
| 18050834 | METHODS AND COMPOSITIONS FOR THE PURIFICATION OF ADENO-ASSOCIATED VIRUS | BURKHART, MICHAEL D | 45d overdue |
| 18003124 | ENDOTHELIAL CELLS FOR MITIGATION OF CHEMOTHERAPY-INDUCED TOXICITY | SCHUBERG, LAURA J | 25d overdue |
| 18099486 | MAGNETIC INTERVERTEBRAL DISC REPLACEMENT DEVICES AND METHODS THEREOF | RAMANA, ANURADHA | 29d |
| 17821884 | ADENO-ASSOCIATED VIRUS FORMULATIONS | GILL, RACHEL B | 29d |
| 18411193 | Pharmaceutical Composition and Method for Improving Biomechanical Integrity of the Pelvic Floor | TCHERKASSKAYA, OLGA V | 30d |
| 18099505 | MAGNETIC INTERVERTEBRAL DISC REPLACEMENT DEVICES AND METHODS THEREOF | RAMANA, ANURADHA | 30d |
| Client (Assignee) | Pending OAs |
|---|---|
| Oxford Biomedica | 5 |
| Fempharma, LLC | 2 |
| Gomboc | 2 |
| GEORGETOWN UNIVERSITY | 1 |
| ANGIOCRINE BIOSCIENCE, INC. | 1 |
| UCL BUSINESS LTD | 1 |
| Nunona Inc. | 1 |
| Johnson & Johnson | 1 |
| Ospedale San Raffaele S.R.I. | 1 |
| Shuttle Pharmaceuticals Holdings, Inc. | 1 |
| LMU Klinikum | 1 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1 |
| Art Unit | Apps |
|---|---|
| 3775 | 2 |
| 1631 | 2 |
| 1638 | 2 |
| 1614 | 1 |
| 1615 | 1 |
| 1628 | 1 |
| 1672 | 1 |
| 1671 | 1 |
| 1634 | 1 |
| 1792 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18622971 | Pharmaceutical Composition and Method for Treating or Preventing Candidiasis | Fempharma, LLC | YU, HONG | 1614 | §103 | Non-Final OA | 22d | Pending | Mar 31, 2024 |
| 18411193 | Pharmaceutical Composition and Method for Improving Biomechanical Integrity of the Pelvic Floor | Fempharma, LLC | TCHERKASSKAYA, OLGA V | 1615 | §112 | Non-Final OA | 30d | Pending | Jan 12, 2024 |
| 18138058 | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Georgetown University | BARSKY, JARED | 1628 | §103 | Non-Final OA | 89d overdue | Pending | Apr 22, 2023 |
| 18099505 | MAGNETIC INTERVERTEBRAL DISC REPLACEMENT DEVICES AND METHODS THEREOF | Gomboc, LLC | RAMANA, ANURADHA | 3775 | §103 | Final Rejection | 30d | Pending | Jan 20, 2023 |
| 18099486 | MAGNETIC INTERVERTEBRAL DISC REPLACEMENT DEVICES AND METHODS THEREOF | Gomboc, LLC | RAMANA, ANURADHA | 3775 | §103 | Final Rejection | 29d | Pending | Jan 20, 2023 |
| 18003124 | ENDOTHELIAL CELLS FOR MITIGATION OF CHEMOTHERAPY-INDUCED TOXICITY | Angiocrine Bioscience, Inc. | SCHUBERG, LAURA J | 1631 | Other | Non-Final OA | 25d overdue | Pending | Dec 22, 2022 |
| 18066567 | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF ADENO-ASSOCIATED VIRUS | Oxford Biomedica (Us) LLC | GONZALES, JOSEPHINE MARIA | 1631 | §103 | Non-Final OA | 69d | Pending | Dec 15, 2022 |
| 18009320 | CHIMERIC ANTIGEN RECEPTOR CELL | UCL Business Ltd | HILL, KEVIN KAI | 1638 | §103 | Final Rejection | 86d overdue | Pending | Dec 08, 2022 |
| 18050834 | METHODS AND COMPOSITIONS FOR THE PURIFICATION OF ADENO-ASSOCIATED VIRUS | Oxford Biomedica (Us) LLC | BURKHART, MICHAEL D | 1638 | Other | Non-Final OA | 45d overdue | Pending | Oct 28, 2022 |
| 17909427 | Replication Competent Virus Assay | Oxford Biomedica (Uk) Limited | WANG, RUIXUE | 1672 | §103 | Non-Final OA | 69d | Pending | Sep 05, 2022 |
| 17821884 | ADENO-ASSOCIATED VIRUS FORMULATIONS | Oxford Biomedica (Us) LLC | GILL, RACHEL B | 1671 | §103 | Final Rejection | 29d | Pending | Aug 24, 2022 |
| 17775922 | Production System | Oxford Biomedica (Uk) Limited | PENNINGTON, KATIE LEIGH | 1634 | §103 | Final Rejection | 30d | Pending | May 11, 2022 |
| 17724493 | PLANT-BASED BABY FOOD COMPOSITIONS | Nunona Inc. | NGUYEN, THANH H | 1792 | §103 | Non-Final OA | 15d | Pending | Apr 20, 2022 |
| 17509889 | Methods of Reducing Tau in Human Subjects | Janssen Pharmaceutica NV | WANG, CHANG YU | 1675 | Other | Non-Final OA | 44d overdue | Pending | Oct 25, 2021 |
| 17503088 | Gene Therapy | Ospedale San Raffaele S.R.I. | CORDAS, EMILY ANN | 1632 | §103 | Non-Final OA | 69d | Pending | Oct 15, 2021 |
| 17476148 | PREDICTIVE BIOMARKERS FOR ADVERSE EFFECTS OF RADIATION THERAPY | Shuttle Pharmaceuticals Holdings, Inc. | LIMBAUGH, KATHRYN ELIZABETH | 1797 | §103 | Final Rejection | 6d | Pending | Sep 15, 2021 |
| 17435634 | CCR8 EXPRESSING LYMPHOCYTES FOR TARGETED TUMOR THERAPY | Klinikum Der Universitat Munchen | WESTON, ALYSSA G | 1633 | §102 | Non-Final OA | 98d overdue | Pending | Sep 01, 2021 |
| 17196631 | METHODS AND COMPOSITIONS FOR DETECTION OF HPV DNA AND DIAGNOSIS AND MONITORING OF HPV-ASSOCIATED CANCERS | Memorial Sloan Kettering Cancer Center | HANEY, AMANDA MARIE | 1682 | §103 | Non-Final OA | 7d | Pending | Mar 09, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial